We are live on ! Find out more
MLL

Moody Lynn & Lieberson Portfolio holdings

AUM $1.9B
1-Year Est. Return 27.82%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$937M
AUM Growth
+$115M
Cap. Flow
-$2.54M
Cap. Flow %
-0.27%
Top 10 Hldgs %
29.62%
Holding
230
New
21
Increased
73
Reduced
77
Closed
23

Top Buys

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$13.7M
2
BIIB icon
Biogen
BIIB
+$11.6M
3
ITW icon
Illinois Tool Works
ITW
+$10.4M
4
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$9.01M
5
C icon
Citigroup
C
+$7.24M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$16.6M
2
FRC
First Republic Bank
FRC
+$11.7M
3
BCR
CR Bard Inc.
BCR
+$6.76M
4
GD icon
General Dynamics
GD
+$5.71M
5
GLD icon
SPDR Gold Trust
GLD
+$5.55M

Sector Composition

Rank Sector Weight
1 Financials 20.83%
2 Industrials 15.41%
3 Healthcare 11.28%
4 Technology 10.72%
5 Communication Services 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
51
Charles Schwab
SCHW
$183B
$5.42M 0.58%
101,965
+37,765
+59% +$1.77M
LLL
52
DELISTED
L3 Technologies, Inc.
LLL
$4.89M 0.52%
22,800
+3,210
+16% +$611K
ISRG icon
53
Intuitive Surgical
ISRG
$127B
$4.58M 0.49%
+32,091
New +$4.02M
PSX icon
54
Phillips 66
PSX
$84.9B
$4.25M 0.45%
41,572
+2,828
+7% +$269K
VRTX icon
55
Vertex Pharmaceuticals
VRTX
$121B
$3.94M 0.42%
+23,640
New +$3.5M
MRK icon
56
Merck
MRK
$322B
$3.55M 0.38%
61,371
-54,081
-47% -$3M
XOM icon
57
ExxonMobil
XOM
$644B
$3.54M 0.38%
40,776
+81
+0.2% +$6.7K
NOW icon
58
ServiceNow
NOW
$115B
$3.29M 0.35%
+112,325
New +$2.79M
ABMD
59
DELISTED
Abiomed Inc
ABMD
$3.24M 0.35%
+13,775
New +$2.57M
BXMT icon
60
Blackstone Mortgage Trust
BXMT
$2.45B
$3.19M 0.34%
101,463
-938
-0.9% -$30.1K
BLK icon
61
Blackrock
BLK
$169B
$3.06M 0.33%
5,443
+229
+4% +$111K
AVGO icon
62
Broadcom
AVGO
$1.85T
$2.89M 0.31%
120,050
-75,200
-39% -$1.95M
IWM icon
63
iShares Russell 2000 ETF
IWM
$79.8B
$2.82M 0.3%
17,949
+4,040
+29% +$607K
TTWO icon
64
Take-Two Interactive
TTWO
$45.4B
$2.65M 0.28%
22,403
-20,062
-47% -$2.19M
IWO icon
65
iShares Russell 2000 Growth ETF
IWO
$14.3B
$2.59M 0.28%
13,274
– –
DIS icon
66
Walt Disney
DIS
$167B
$2.53M 0.27%
22,969
-111
-0.5% -$11.4K
KO icon
67
Coca-Cola
KO
$377B
$2.48M 0.26%
52,323
+8,496
+19% +$391K
MO icon
68
Altria Group
MO
$114B
$2.44M 0.26%
34,873
-471
-1% -$31.6K
PX
69
DELISTED
Praxair Inc
PX
$2.43M 0.26%
15,094
+80
+0.5% +$11.9K
MDT icon
70
Medtronic
MDT
$109B
$2.34M 0.25%
27,211
-24,145
-47% -$1.93M
CMI icon
71
Cummins
CMI
$87.5B
$2.29M 0.24%
12,245
-4,294
-26% -$734K
CHD icon
72
Church & Dwight Co
CHD
$23.4B
$2.22M 0.24%
45,239
-159
-0.4% -$7.46K
BDX icon
73
Becton Dickinson
BDX
$45.6B
$2.14M 0.23%
9,018
+7,934
+732% +$1.66M
IWN icon
74
iShares Russell 2000 Value ETF
IWN
$14.3B
$2.12M 0.23%
16,613
+6,125
+58% +$766K
IWF icon
75
iShares Russell 1000 Growth ETF
IWF
$121B
$2.11M 0.22%
58,604
-4,440
-7% -$146K
1 2
3
4 5

Similar funds

EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
OPCM
Osborne Partners Capital Management San Francisco, California $1.89B AUM 16.21% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM

Moody Lynn & Lieberson's Q4 2017 Portfolio in Review

As of Q4 2017, Moody Lynn & Lieberson held 230 positions worth $937M, up 14% from $822M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Moody Lynn & Lieberson's Q4 2017 filing shows 21 new, 73 increased, 77 reduced and 23 closed positions. Its largest new stake was Biogen: 36,202 shares worth $12.8M. The largest sale was Celgene Corp, an estimated $16.6M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Moody Lynn & Lieberson's largest Q4 2017 buy was Biogen: 36,202 shares worth $12.8M.
  • Moody Lynn & Lieberson added most to Vanguard FTSE Emerging Markets ETF in Q4 2017, an estimated $13.7M increase.
  • Moody Lynn & Lieberson's biggest Q4 2017 reduction was SPDR Gold Trust, cutting an estimated $5.55M.
  • Moody Lynn & Lieberson fully exited Celgene Corp in Q4 2017, selling an estimated $16.6M.
  • Moody Lynn & Lieberson's ten largest holdings make up 30% of its $937M portfolio in Q4 2017.
  • Moody Lynn & Lieberson opened 21 new positions and closed 23 in Q4 2017.
  • Moody Lynn & Lieberson's portfolio value rose 14% quarter-over-quarter to $937M.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2017, filed 2 Feb 2018.